Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


VIDEO from Medialink and the Society of Interventional Radiology: Interventional Cryoablation Stops Cancer Cold

          New treatment for patients with localized kidney cancer

    NEW YORK, March 17 /PRNewswire/ -- Imagine finding out that you have
kidney cancer and that you'll need 6 hours of surgery with up to 2 months
recovery to remove the tumor. And, then, shortly before your scheduled
surgery, you learn from a friend or the internet that you can be cured with
a 90 minute out-patient procedure. That's what happened to this man.

    See video from the Society of Interventional Radiology at:
http://media.medialink.com/WebNR.aspx?story=34816

    Alan Jacobs learned about a treatment performed by interventional
radiologists. Interventional cryoablation is a minimally invasive,
outpatient procedure that is relatively painless. Using imaging to pinpoint
the tumor, an interventional radiologist guides a probe through the skin to
the tumor and then releases gas to freeze it. The freezing process kills
the tumor. Patients leave the hospital with only a band-aid and return to
normal activity almost immediately.

    Interventional Radiologists are physicians who specialize in minimally
invasive, targeted treatments that offer less risk, less pain and less
recovery time compared to open surgery.

    Until now, the only option for patients with kidney cancer was several
hours of surgery, a week in the hospital and 4 to 6 weeks of recovery.
Patients not eligible for surgery or those with small tumors that have not
spread beyond the kidney, now have another option. People who are too sick
for surgery, can't have general anesthesia, have borderline kidney
function, only one kidney or multiple recurring tumors had no option till
now.

    Interventional cryoablation is approved by the FDA for soft tissue
tumors, like kidney cancer. Even though it is a new treatment, it is
offered throughout the United States

    More than 32,000 Americans each year are diagnosed with kidney cancer.
It is the 8th most common cancer in men and the 10th in women. Typically
those with kidney cancer are past the age of 40 and are twice as likely to
be men. Other risk factors include smoking, obesity, high blood pressure,
long-term dialysis and Von Hippel-Lindau syndrome.

    Registered journalists can access video, audio, text, graphics and
photos for free and unrestricted use at http://www.mediaseed.tv.

    03DC08-0097



SOURCE Medialink and the Society of Interventional Radiology




Back to Topback to top

Related links:
  • http://media.medialink.com/WebNR.aspx?story=34816
  • http://www.mediaseed.tv
  • http://www.sirweb.org/news/newsPDF/2008am/Mon/Renal_cryoFinal.pdf
    CONTACT:
    Medialink, New York, +1-888-560-5578,
    mediadesk@medialink.com